ESR1 and Bartsocas-Papas syndrome 1: The most commonly used drugs within the AOM group were BPs (19 cases), followed by vitamin D3 (15 cases); selective estrogen receptor modulators (SERMs) were used in 6 cases, teriparatide in 3 cases, and denosumab and methotrexate in 2 cases each (Fig. 1).